Showing results (471-480 of 543) with videos related to

Sort By:
Pageof 55
British Journal of Cancer|January 28, 2010
p53 mutation, deprivation and poor prognosis in primary breast cancerL Baker, P R Quinlan, N Patten, et al.
Cytometry. Part B, Clinical Cytometry|March 17, 2009
A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiencyRebecca A Marsh, Joyce Villanueva, Kejian Zhang, et al.
Vaccine|October 13, 2023
Bacterial production of recombinant contraceptive vaccine antigen from CatSper displayed on a human papilloma virus-like particleK N Nand, T B Jordan, X Yuan, et al.
Critical Care Medicine|October 22, 2019
Host-Response Subphenotypes Offer Prognostic Enrichment in Patients With or at Risk for Acute Respiratory Distress SyndromeGeorgios D Kitsios, Libing Yang, Dimitris V Manatakis, et al.
Pediatric Blood & Cancer|April 24, 2012
Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumabRebecca A Marsh, Carl E Allen, Kenneth L McClain, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 12, 2018
Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte SocietyStephan Ehl, Itziar Astigarraga, Tatiana von Bahr Greenwood, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 20, 2014
Perforin gene transfer into hematopoietic stem cells improves immune dysregulation in murine models of perforin deficiencyMarlene Carmo, Kimberly A Risma, Paritha Arumugam, et al.
Nanotechnology|March 31, 2017
Nanoselective area growth of defect-free thick indium-rich InGaN nanostructures on sacrificial ZnO templatesRenaud Puybaret, David J Rogers, Youssef El Gmili, et al.
Cancer Research|November 19, 2010
Differential contextual responses of normal human breast epithelium to ionizing radiation in a mouse xenograft modelPhilip J Coates, M Virginia C L Appleyard, Karen Murray, et al.
Plos One|May 4, 2018
Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-VBryan D Moyer, Justin K Murray, Joseph Ligutti, et al.
Pageof 55